The standard description of Wegener's granulomatosis emphasises renal failure and thus a distorted impression may be given. Subacute and even chronic cases occur, and in these patients the presentation is varied and often insidious, leading to delay in diagnosis. Twenty two such patients (13 women and nine men) with a mean age of 44 years were seen in our connective tissue disease clinic. The mean duration of symptoms before diagnosis was 3-6 years and the mean duration of disease 5.9 years (19 years in one patient). All patients had malaise and ear, nose, and throat symptoms, and most had joint pains. Impaired renal function was seen in seven patients only. Tissue biopsy was diagnostic in half of the patients, and appreciably high titres of antineutrophil cytoplasmic antibodies were detected in only nine of 18 patients in whom these were measured. The most useful investigations were neutrophil counts, chest radiographs, and computed tomography of the sinuses and orbits. The most effective treatment was with intravenous pulses of cyclophosphamide. No deaths occurred. At the time of writing two patients were in remission and no longer being treated and 18 patients were in partial remission on continued treatment.
Introduction
The BMJ VOLUME 299 the careful exclusion of other diseases. Supportive evidence came from laboratory investigations and histological specimens (table I) . There were 13 women and 9 men whose mean age was 44 years (range 29-73 years). The mean duration of symptoms before diagnosis was 3-6 years (range 0-2-19 years), and the mean total duration of disease was 5*9 years (range 0-3-19 years).
PRESENTING FEATURES (TABLE II) All 22 patients had systemic features of fever, malaise, and weight loss, and most had joint pains. All had ear, nose, and throat symptoms either at presentation or later. These were often minor or the patient thought that they were not relevant until questioned about them. Pulmonary and eye symptoms were common but appreciable renal disease was unusual.
Nose-All 22 patients had nasal symptoms, the commonest features being sinusitis (15) with nasal discharge (15), nasal stuffiness (13), and facial pain (seven). Four patients had nasal crusting, suggesting inflammation of the nasal mucosa, and 12 had nosebleeds, which were often heavy. Six patients had an altered sense of smell, six had pain at the nasal bridge, which suggested nasal chondritis, and in six the nasal bridge had collapsed, two of these patients needing reconstructive surgery.
Ear-Fifteen patients had disease of the ear, the commonest presenting features being conductive deafness (13) and pain (11) . Eight had a discharge, often purulent, six had serous otitis media, and three had otitis externa.
Throat-Twelve patients had throat symptoms, pain being the commonest symptom in 10 Skin-Twelve patients had evidence of vasculitis. In three patients diagnostic skin biopsies showed a leucocytoclastic vasculitis, and two developed splinter haemorrhages in association with the vasculitis. Other patients had nodules/papules (four), bruises (five), urticarial vasculitis (one), photosensitivity (one), and necrotic vasculitis ulcers causing rupture of tendons (one).
Other organs-Five patients had peripheral neuropathy. One developed mononeuritis multiplex. One patient had arrhythmias.
Renal (TABLE IV) Most patients had negative or weakly positive serology for antinuclear antibodies and antibodies to antideoxyribonucleic acid measured by Cnthidia and binding assays. Seven patients had a positive rheumatoid factor, the Rose-Waaler titre ranging from 1/4 to 1/2560. None of these had evidence of renal disease. Five of 13 patients had high complement activity. Most patients had detectable concentrations of immune complexes by the polyethylene glycol precipitation method, and one patient had detectable concentrations of cryoglobulins. Five patients had minor non-specific abnormalities of liver function: raised serum alkaline phosphatase activity (five) and raised serum alanine transaminase activity (three). (fig 1) . Radiographs of the sinuses showed opacification or fluid levels in 15 patients. Computed tomography of the sinuses and orbits delineated the extent of the abnormality in the sinus in 11 patients with erosion of bone shown clearly. In three patients intraorbital granulomatous masses were found which had not been suspected clinically, and in one patient a small granulomatous mass at the orbital apex resulted in optic nerve compression (figs 2-4). The rapidly developing blindness, however, improved with treatment.
BMJ VOLUME 299 12 AUGUST 1989 HISTOLOGY Diagnostic appearances of giant cell granulomas, vasculitis, and necrosis were seen in only eight patients after biopsy of the nasal mucosa, and two of the biopsy specimens showed non-specific inflammation or necrosis.
Four patients underwent renal biopsy and all showed the histological findings of glomerulonephritis: proliferative glomerulonephritis (two), mesangiocapillary crescentic glomerulonephritis (one), and segmental necrotising glomerulonephritis (one).
Four patients had lung biopsies (three of which were open lung biopsies), and only one had diagnostic appearances. Three skin biopsy specimens showed a leucocytoclastic vasculitis. One patient had several biopsies of a sternal mass, which showed non-specific necrotic tissue.
ANTINEUTROPHIL CYTOPLASMIC ANTIBODY
Antineutrophil cytoplasmic antibody titres were measured in 18 patients using radioimmunoassay and immunofluorescence. In eight of these patients the serum was assayed after treatment had begun. Positive results were seen in nine. Seven of the 18 patients were strongly positive with high titres, while two were positive with borderline raised titres. The other nine assayed were negative.
TREATMENT
All patients received oral prednisolone, and five patients also received intravenous pulses of methyl- FIG The most effective regimen for inducing remission was intravenous pulses of cyclophosphamide (500-750 mg) at weekly intervals for three to four weeks followed by low doses of oral cyclophosphamide (1-2 mg/kg). Intravenous pulses of methylprednisolone (0 5-1 g) were given when indicated and oral steroids were given at a dose of 30-40 mg/day and this was reduced as the patient responded to treatment. Azathioprine was less effective in inducing or maintaining remission.
Complete remission was defined as the complete absence of active disease. Partial remission was defined as clearly reduced disease activity and progress towards improvement; renal function and pulmonary infiltrates were stable or showing signs of resolution.
At the time of writing only two patients were in complete remission and receiving no treatment. Eighteen others were maintained in partial remission with continued treatment. Two patients showed a poor response despite intensive treatment, and one required renal dialysis. No patient died.
Most patients responded promptly to treatment, showing a good response within two weeks. Although remission was maintained with treatment, there were difficulties in controlling some symptoms. In particular, symptoms in the ear, nose, throat, and eye were the most difficult to manage effectively.
To reduce the adverse effects of treatment the dose of oral prednisolone was reduced rapidly to [10] [11] [12] [13] [14] [15] mg/day once the patient was clearly responding. The dose of oral cyclophosphamide was maintained for at least one year and gradually reduced while the patient was monitored closely for evidence of relapse.
Treatment with pulses of cyclophosphamide was well tolerated, although a few patients experienced nausea during the infusion. In five patients bone marrow was suppressed with oral cyclophosphamide: two had neutropenia, two thrombocytopenia, and one aplastic anaemia. All recovered when cyclophospha-mide was stopped. Three patients lost hair, two had herpes infections (one herpes simplex and one herpes zoster). One developed Aspergillus fumigatus in a lung cavity, which was probably related to cyclophosphamide. No haemorrhagic cystitis occurred, although patients were closely monitored for this. In addition, no patient developed a malignancy associated with immunosuppression, though they are being followed up.
Discussion
Patients with classical Wegener's granulomatosis are often diagnosed rapidly because of prominent renal and pulmonary disease. But in our patients the presentation was insidious in 15, and the various changing symptoms, especially in the absence of overt renal disease, led to often considerable delay in making the diagnosis. In one case a patient suffered mild to moderate ear, nose, throat, and pulmonary symptoms for 19 years (and had been considered to have systemic lupus erythematosus and was treated with variable doses of steroids) before Wegener's granulomatosis was diagnosed.
The clinical presentation was diverse with features changing as the disease developed. Although all patients had ear, nose, and throat symptoms, these symptoms often had to be elicited by direct questioning as patients thought that they were irrelevant to their current illness.
In previous studies of Wegener's granulomatosis nearly all patients had abnormal chest radiographs.6'9 Only 13 of our 22 patients had abnormalities on chest radiography, however, and this lower figure probably reflects the different spectrum of disease seen in our series of patients. None of our patients had symptoms of asthma and this, together with the few with eosinophilia and the rarity of cardiac disease, differs from our clinical experience of Churg-Strauss syndrome.'0
As in previous studies, the respiratory symptoms responded rapidly to treatment but the changes seen on x ray films, especially the solitary or cavitating nodules, took several weeks or months to clear.
The laboratory findings in our patients showed the characteristic but non-specific features associated with vasculitis in Wegener's granulomatosis-that is, neutrophil leucocytosis, anaemia, thrombocytosis, high erythrocyte sedimentation rate, and raised concentrations of C reactive protein. Immune complexes, detected in moderate concentrations by the polyethylene glycol precipitation method, were seen in 20 patients but were unhelpful diagnostically.
Few biopsy specimens of nasal mucosa yielded diagnostic findings, which almost certainly reflects the fact that it is difficult to obtain adequate amounts of material from biopsy of areas to which access is difficult. With the more widespread use of sinus endoscopy and computed tomography to guide biopsy the yields may be greater.
The antineutrophil cytoplasmic antibody assay was found to be a specific and sensitive test for Wegener's granulomatosis in other studies.''4 We found a relatively low incidence of this antibody, and the results were confirmed by two other laboratories which assayed the sera. There may be several explanations for this. For example, our patients had a different spectrum of disease without renal failure, and the assay was performed on serum taken from eight patients who had already started treatment.
The treatment regimen was generally effective at inducing remission but less successful in maintaining it. There were no deaths, and most of the patients responded quickly. Our study lends further support to the use of cyclophosphamide as the mainstay of treatment in this disease.79 '5 Indeed the condition of several of our patients had been deteriorating With steroid treatment alone before diagnosis. Azathioprine remains a useful alternative drug when cyclophosphamide is not tolerated. We used no other immunosuppressive drugs.
In contrast with the results of previous studies there were no instances of haemorrhagic cystitis, although the patients were carefully monitored for this. The adverse effects were otherwise similar to those in other studies. The association of malignancy with long term cyclophosphamide use'6 has yet to be determined in our series of patients and must await longer follow up.
Though the diagnosis and treatment of fulminant Wegener's granulomatosis is usually clear cut, our results show that this is not true of the subacute forms, in which lesions may recur for over a decade.
Cyclophosphamide remains the most effective treatment, but the use of "standardised" regimens for managing Wegener's granulomatosis may need reconsidering in the light of experience with chronic and subacute forms of the disease.
